22nd Century Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by 22nd Century Group, Inc. (Nasdaq: XXII) on December 23, 2021. The report discloses a material event under Item 7.01 (Regulation FD Disclosure) regarding a regulatory milestone achieved by the Company.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory announcement rather than financial performance data.
Material Changes and Events
- Regulatory Authorization: On December 23, 2021, the Company received Modified Risk Tobacco Product (MRTP) authorization from the U.S. Food and Drug Administration (FDA).
- Product Scope: The authorization applies to the Company's VLN reduced nicotine content cigarettes.
Guidance, Outlook, and Risks
The filing incorporates a press release (Exhibit 99.1) detailing the FDA authorization. The text provided does not contain specific forward-looking guidance, updated financial outlook, or a detailed discussion of risks and contingencies beyond the context of the regulatory approval.
Investor Verification Checklist
- Verify the specific terms and limitations of the FDA Modified Risk Tobacco Product authorization for VLN cigarettes.
- Review the full text of the press release (Exhibit 99.1) for details on marketing implications and potential revenue impact.
- Confirm the Company's current cash position and liquidity status in the most recent 10-Q or 10-K filing, as this 8-K does not contain financial statements.